Reversal of epigenetic silencing rescues integrase-deficient HIV-1 replication
逆转表观遗传沉默可挽救整合酶缺陷的 HIV-1 复制
基本信息
- 批准号:10369728
- 负责人:
- 金额:$ 19.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-10 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressApplications GrantsAreaCD4 Positive T LymphocytesCell LineCell NucleusCellsCharacteristicsChromatinCircular DNAClustered Regularly Interspaced Short Palindromic RepeatsComplexCytoplasmDNADataDepositionDetectionDrug TargetingEnzymesEpigenetic ProcessGene ExpressionGene SilencingGenetic ScreeningGenetic TranscriptionGenomeGoalsGrantHIV IntegraseHIV-1HIV-1 integraseHepatitis B VirusHerpesviridaeHerpesvirus 1HumanHuman T-Cell Leukemia Virus Type I tax ProteinHuman T-lymphotropic virus 1Immediate-Early ProteinsImmunologic FactorsInfectionIntegraseLaboratoriesLengthLifeLife Cycle StagesLightMediatingMutagenesisNF-kappa BNonstructural ProteinNuclearPathway interactionsPatientsPharmaceutical PreparationsPhysiologicalPlayProteinsProvirusesREL ProteinRNARegulationReportingRetroviridaeReverse TranscriptionRoleSiteT-LymphocyteTaxesTranscriptional ActivationUbiquitinationViralViral Proteinsbaseblocking factorchromatin modificationepigenetic silencingextrachromosomal DNAgenome-widemutantpreventpromoterrecruittax Gene Productstranscription factorviral DNA
项目摘要
ABSTRACT
After reverse transcription in the cytoplasm, retroviral DNAs enter the nucleus naked and are then detected
by currently unknown innate immune factors and coated with repressive chromatin. However, retroviruses
encode an integrase (IN) which allows the proviral DNA to be inserted into transcriptionally active areas of the
host genome, which then results in the repressive chromatin marks on the retroviral DNA being replaced by the
active marks characteristic of the flanking host chromatin. If IN activity is blocked either by mutagenesis or by a
drug, then the unintegrated retroviral DNA remains covered with inhibitory chromatin and is transcriptionally
silenced. This grant proposes has two goals. Firstly, I hypothesize that if unintegrated HIV-1 DNA is
epigenetically silenced then it should be possible to activate that DNA, and rescue the replication of IN- HIV-1,
by either directly activating the HIV-1 LTR promoter and/or by directly reversing the epigenetic silencing. We
have now shown that expression of the HTLV-1 Tax protein, a potent activator of cellular NK-kB/Rel transcription
factors, induces the recruitment of RelA and RelB to the NF-kB sites present in the HIV-1 LTR and also prevents
or reverses the epigenetic silencing of unintegrated HIV-1 DNA, allowing IN- HIV-1 mutants to mount a robust,
spreading infection in CEM-SS cells. It remains unclear whether transcriptional activation of the HIV-1 LTR
occurs before or after the change in epigenetic marks on the viral DNA, and this is something we wish to address,
including in primary T cells. We now report preliminary data, obtained in 293T cells, showing that the HSV-1
ICP0 protein can also rescue IN- HIV-1 gene expression, in this case by apparently directly regulating the
epigenetic status of unintegrated HIV-1 DNA. We aim to extend this analysis to T cells to see if ICP0 is indeed
rescuing IN- HIV-1 gene expression via a different mechanism than Tax. Finally, while the factors that recognize
and silence IN- MLV have been identified by the Goff laboratory as the HUSH complex acting in concert with
NP220, we show that these factors are not required to silence IN- HIV-1. A key goal of this application is therefore
to perform an unbiased CRISPR/Cas genetic screen to identify the human innate immune factors that perform
this task and then define their mechanism of action.
抽象的
在细胞质中逆转录后,逆转录病毒DNA进入核核,然后被检测到
通过目前未知的先天免疫因子,并涂有抑制性染色质。但是,逆转录病毒
编码一个集成酶(in),该集成酶允许病毒DNA插入
宿主基因组,然后导致逆转录病毒DNA上的抑制性染色质标记被替代
侧翼宿主染色质的活性标记特征。如果在活动中被诱变阻断或
药物,然后,未整合的逆转录病毒DNA仍被抑制性染色质覆盖,并且是转录的
沉默。该赠款提出有两个目标。首先,我假设如果没有集成的HIV-1 DNA为
表观遗传沉默,然后应该有可能激活该DNA,并挽救HIV-1的复制,
通过直接激活HIV-1 LTR启动子和/或直接逆转表观遗传沉默。我们
现在已经表明了HTLV-1税收蛋白的表达,这是细胞NK-KB/rel转录的有效激活因子
因素,诱导RELA和RELB募集到HIV-1 LTR中存在的NF-KB位点,也可以防止
或逆转未集成的HIV-1 DNA的表观遗传沉默,使HIV-1突变体可以安装强大的,
在CEM-SS细胞中传播感染。尚不清楚HIV-1 LTR的转录激活是否
发生在病毒DNA上表观遗传标记变化之前或之后,这是我们希望解决的问题,
包括原代T细胞。现在,我们报告了在293T细胞中获得的初步数据,表明HSV-1
ICP0蛋白还可以通过显然直接调节这种情况来挽救HIV-1基因表达
未集成的HIV-1 DNA的表观遗传状态。我们旨在将此分析扩展到T细胞,以查看ICP0是否确实是
通过与税收不同的机制来营救HIV-1基因表达。最后,而识别的因素
戈夫实验室已经确定了寂静的In-mlv是与之共同行动
NP220,我们表明这些因素不需要沉默HIV-1。因此,此应用程序的关键目标是
执行无偏见的CRISPR/CAS遗传筛选,以识别执行的人类先天免疫因素
这项任务,然后定义他们的作用机理。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency.
- DOI:10.1038/s41564-022-01264-z
- 发表时间:2022-12
- 期刊:
- 影响因子:28.3
- 作者:
- 通讯作者:
The SMC5/6 complex: An emerging antiviral restriction factor that can silence episomal DNA.
- DOI:10.1371/journal.ppat.1011180
- 发表时间:2023-03
- 期刊:
- 影响因子:6.7
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRYAN R. CULLEN其他文献
BRYAN R. CULLEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRYAN R. CULLEN', 18)}}的其他基金
Reversal of epigenetic silencing rescues integrase-deficient HIV-1 replication
逆转表观遗传沉默可挽救整合酶缺陷的 HIV-1 复制
- 批准号:
10158875 - 财政年份:2021
- 资助金额:
$ 19.74万 - 项目类别:
Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
HIV-1 转录本的表观转录组修饰:滥用药物的影响
- 批准号:
10371249 - 财政年份:2018
- 资助金额:
$ 19.74万 - 项目类别:
Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
HIV-1 转录本的表观转录组修饰:滥用药物的影响
- 批准号:
9894777 - 财政年份:2018
- 资助金额:
$ 19.74万 - 项目类别:
Effect of m6A editing of RNA on influenza A virus replication
RNA m6A 编辑对甲型流感病毒复制的影响
- 批准号:
9296268 - 财政年份:2017
- 资助金额:
$ 19.74万 - 项目类别:
Disruption of latent HIV-1 proviruses using CRISPR/Cas endonucleases
使用 CRISPR/Cas 核酸内切酶破坏潜伏的 HIV-1 原病毒
- 批准号:
9427958 - 财政年份:2015
- 资助金额:
$ 19.74万 - 项目类别:
Using bacterial CRISPR/Cas endonucleases to selectively eliminate HPV-transformed cells in vivo
使用细菌 CRISPR/Cas 核酸内切酶选择性消除体内 HPV 转化细胞
- 批准号:
9136078 - 财政年份:2015
- 资助金额:
$ 19.74万 - 项目类别:
Reconstitution of a protective antiviral RNAi response in somatic human cells
重建人体细胞中保护性抗病毒 RNAi 反应
- 批准号:
8849841 - 财政年份:2014
- 资助金额:
$ 19.74万 - 项目类别:
Reconstitution of a protective antiviral RNAi response in somatic human cells
重建人体细胞中保护性抗病毒 RNAi 反应
- 批准号:
8762673 - 财政年份:2014
- 资助金额:
$ 19.74万 - 项目类别:
Role and mechanism of action of gamma herpesvirus microRNAs
γ 疱疹病毒 microRNA 的作用和作用机制
- 批准号:
8293437 - 财政年份:2011
- 资助金额:
$ 19.74万 - 项目类别:
相似海外基金
Influence of Particulate Matter on Fetal Mitochondrial Programming
颗粒物对胎儿线粒体编程的影响
- 批准号:
10734403 - 财政年份:2023
- 资助金额:
$ 19.74万 - 项目类别:
Defining single-channel paracellular (tight junction) conductances using nanotechnology
使用纳米技术定义单通道旁细胞(紧密连接)电导
- 批准号:
10593421 - 财政年份:2023
- 资助金额:
$ 19.74万 - 项目类别:
Effect of chronic ethanol exposure on synaptic organization in the rostromedial tegmental nucleus
慢性乙醇暴露对吻内侧被盖核突触组织的影响
- 批准号:
10809364 - 财政年份:2023
- 资助金额:
$ 19.74万 - 项目类别:
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
将接受阿片类药物使用障碍治疗且吸烟的个体转至 SREC
- 批准号:
10661301 - 财政年份:2023
- 资助金额:
$ 19.74万 - 项目类别: